direct to consumer tirzepatide Direct-to-consumer prescription drug programs: Plan sponsors beware! Lilly releases Zepbound® (tirzepatide) single-dose

Patients who may benefit from an agent that assists with weight loss alongside glucose control

Resveratrol Vitamin C Lip Balm 15g / 0.53 fl

Practical help in 4 modules Module 1 Webinar Now available On Demand Understanding the issues around the GLP-1 RA shortage Understanding the impact of the current GLP-1 RA shortage Making sense of the guidance published Identifying and prioritising those affected Practical resources to support clinicians Plus downloadable guides: Module 2 Webinar Now available On Demand Tackling the GLP-1 RA shortage in clinical practice: A consultation guide Applying national guidance in practice Promoting patient-centred discussion Identifying appropriate alternatives to GLP-1 RAs Working through practical case examples Plus downloadable guides: Module 3 Common patient scenarios Now available on demand Module 4 Webinar Where are we now

This vulnerability underscores the importance of thorough discussions between expectant mothers and their healthcare teams about any medications they are currently taking or considering

Compounded GLP-1 Therapies It is important to distinguish between FDA-approved medications and compounded formulations